Khan Academy’s AI Pilot Program.
Learn About the Launch of Khan Academy's AI Pilot Program on Bloomberg Radio.
Sal...
Video: New Topical Drug Delivery System, NeuroDirect™
Must Watch Video. Topical Application to Improve Delivery of FDA-Approved Drugs.
https://youtu.be/2CGT7P9QEvo
Can...
The Weekly Hack with Alain Ghiai, Internet Privacy Expert.
CEO Interview | Sekur Private Data (SWISF)
https://youtu.be/RKuHDezdJGY?si=krE4gBqBtidR-ika
Septeber 5th, 2023
New to the Street | Newsmax TV | Episode 508
New to the Street 503 | Newsmax TV, Saturday, August 19, 2023
https://youtu.be/0Jd8HOiYx3k?si=DRpuBoot61gfk7nD
August...
Greatest Interview with Arthur Hayes.
38-year-old Arthur Hayes who hails from Detroit, with a estimated net worth of $500 million, and has posted a fantastic interview. It's...
The Extraordinary Dr. Koffman, Who Beat Leukemia.
Dr. Brian Koffman is extraordinary, in many ways. He’s extraordinary in the medical sense because, after twelve years of battling blood...
Interviews With Dr. Don Diamond, Lead Developer in the GeoVax (GOVX) Vaccine for Leukemia...
Dr. Don Diamond has stated, "The City of Hope is excited to license this vaccine to GeoVax (GOVX) to progress to large-scale...
Video: Hapbee Testimonials.
Hapbee is powered by patented ultra-low radio frequency energy (ulRFE®) technology invented by...
Steven Boyd, Armistice Capital Ranked #2 in Rising Hedge Fund Stars (Institutional Investor Magazine).
A handful were born outside the U.S., while others are first-generation Americans. Some were shoo-ins for the Ivy League, while several relied...
Oramed (ORMP) $5.24, Focused on Pill Form Insulin. Is China First?
New technology could revolutionize market of 500 million diabetes patients (i24 News).
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
